Assessing the Magnitude of Anisometropia in Patients Wearing Misight 1 Day Contact Lens

December 19, 2024 updated by: Buddhist Tzu Chi General Hospital
The effectiveness of Misight 1 Day Contact Lens in retarding anisometropic progression has not been investigated before. This study is aimed to elucidate the efficacy of Misight 1 Day Contact Lens for anisometropia control.

Study Overview

Status

Enrolling by invitation

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Estimated)

50

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Hualien City, Taiwan, 97002
        • Shang-Yen WU

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult

Accepts Healthy Volunteers

N/A

Sampling Method

Probability Sample

Study Population

We enroll the clinical patients who was diagnosed with anisometropia (meaning that myopia exceeds 100 degree diopters during the refraction examination, and the difference between the other eye is more than 100 degree diopters). Age limit was 8 to 23 years old. The purpose and process were carefully addressed to the subjects and their guardians who signed an informed consent form before commencing this study.

Description

Inclusion Criteria:

  • 8-23 years old children diagnosed with anisometropia and are willing to accept MiSight® 1 Day contact lens wearing treatment.
  • No congenital eye diseases or eye diseases such as strabismus and amblyopia.
  • Those who have been stated to be willing to participate in the program for at least 24 months and accept various evaluations.

Exclusion Criteria:

  • Ocular surface disease( dry eye, keratoconus..)
  • Allergy to contact lens
  • Received eye surgery before
  • The cornea is infected (bacterial, fungal or viral infection).
  • Strabismus
  • Premature birth

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
myopic children
Myopic children use Misight 1 Day Contact Lens every day for myopia and anisometropia control.
Misight 1 Day Contact Lens wearing for myopia control

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes of the visual acuity in myopic children with different Misight 1 Day Contact Lens
Time Frame: From the date of starting treatment, the visual acuity was measured 1 week, 1month and every 3 months up to 24 months.
The investigators measure the visual acuity of myopic children with different Misight 1 Day Contact Lens.
From the date of starting treatment, the visual acuity was measured 1 week, 1month and every 3 months up to 24 months.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes of axial length in myopic children with different Misight 1 Day Contact Lens
Time Frame: From the date of starting treatment, the axial length was measured, then repeat measure were performed every 6 months up to 24 months
The investigators measure the axial length(mm) of eyeball of myopic children with different diopter of Misight 1 Day Contact Lens.
From the date of starting treatment, the axial length was measured, then repeat measure were performed every 6 months up to 24 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

January 1, 2025

Primary Completion (Estimated)

December 31, 2025

Study Completion (Estimated)

December 31, 2026

Study Registration Dates

First Submitted

December 16, 2024

First Submitted That Met QC Criteria

December 19, 2024

First Posted (Actual)

March 25, 2025

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

December 19, 2024

Last Verified

December 1, 2024

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • IRB113-170-A

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

product manufactured in and exported from the U.S.

Yes

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Myopia

Clinical Trials on Misight 1 Day Contact Lens

Subscribe